Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Margareta Böttiger, Brith Christenson & Lena Grillner. (1997) Hepatitis A immunity in the Swedish population: A Study of the Prevalence of Markers in the Swedish Population. Scandinavian Journal of Infectious Diseases 29:2, pages 99-102.
Read now
Read now
Articles from other publishers (31)
Paloma Carrillo-Santisteve, Lara Tavoschi, Ettore Severi, Sandro Bonfigli, Michael Edelstein, Emma Byström, Pierluigi Lopalco, Valeria Alfonsi, Roman Chilbek, Angela Dominguez, Emmanouil Galanakis, Denisa Janta, Mira Kojouharova, Jördis J Ott, Noele Nelson, Vassiliki Papaevangelou, Daniel Shouval, Ingrid Uhnoo & Vytautas Usonis. (2017) Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review. The Lancet Infectious Diseases 17:10, pages e306-e319.
Crossref
Crossref
Angus Nicoll, Nigel J. Gay & Norman T. Begg. 2010. Topley & Wilson's Microbiology and Microbial Infections. Topley & Wilson's Microbiology and Microbial Infections.
Juan A Del Olmo, Elena Ornia, Miguel A Serra, Maria-Luisa Garcia-Torres, Amparo Escudero, Felicidad Rodriguez & Jose M Rodrigo. (2006) Changing prevalence, clinical features, and outcome of acute hepatitis in Spain (1982-2003). Journal of Gastroenterology and Hepatology 21:6, pages 982-987.
Crossref
Crossref
Zahid Hussain, Bhudev C Das, Syed A Husain, Nandagudi S Murthy & Premashis Kar. (2006) Increasing trend of acute hepatitis A in north India: Need for identification of high-risk population for vaccination. Journal of Gastroenterology and Hepatology 21:4, pages 689-693.
Crossref
Crossref
KH Jacobsen & JS Koopman. (2005) The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. International Journal of Epidemiology 34:3, pages 600-609.
Crossref
Crossref
Àngela Domínguez, Miquel Bruguera, Pere Plans, Josep Costa & Lluís Salleras. (2004) Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization. Journal of Medical Virology 73:2, pages 172-176.
Crossref
Crossref
V. Vargas Blasco. (2004) Hepatitis por otros virus hepatotropos. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:11, pages 666-673.
Crossref
Crossref
Ester Suñén, Nerea Casas, Belén Moreno & Carmen Zigorraga. (2004) Comparison of two methods for the detection of hepatitis A virus in clam samples (Tapes spp.) by reverse transcription-nested PCR. International Journal of Food Microbiology 91:2, pages 147-154.
Crossref
Crossref
A. Gil, A. González, M. San-Martín & P. Carrasco. (2004) Hospitalizaciones por hepatitis A en España (1995–1998). Vacunas 5:2, pages 31-34.
Crossref
Crossref
R. Soriano, G. Tiberio, V. Martínez Artola, N. Casares & F. Berrade. (2004) Seroprevalencia de hepatitis A en Navarra. Revista Clínica Española 204:3, pages 145-150.
Crossref
Crossref
Raymond S. Koff. 2004. Atlas of the Liver. Atlas of the Liver
19
41
.
Allan Linneberg, Christian Østergaard, Michael Tvede, Leif Pervical Andersen, Niels Henrik Nielsen, Flemming Madsen, Lars Frølund, Asger Dirksen & Torben Jørgensen. (2003) IgG antibodies against microorganisms and atopic disease in Danish adults: The Copenhagen Allergy Study. Journal of Allergy and Clinical Immunology 111:4, pages 847-853.
Crossref
Crossref
A. González Praetorius, C. Rodríguez-Avial, C. Fernández, M.T. Pérez Pomata, C. Gimeno & J. Bisquert. (2002) Incidencia y factores de riesgo de hepatitis A en la provincia de Guadalajara. Gastroenterología y Hepatología 25:4, pages 230-234.
Crossref
Crossref
Mehmet Arslan, Russell H. Wiesner, John J. Poterucha & Nizar N. Zein. (2001) SAFETY AND EFFICACY OF HEPATITIS A VACCINATION IN LIVER TRANSPLANTATION RECIPIENTS1, 2. Transplantation 72:2, pages 272-276.
Crossref
Crossref
J.R. de Juanes, A. González, M.P. Arrazola & M. San-Martı́n. (2001) Cost analysis of two strategies for hepatitis A vaccination of hospital health-care personnel in an intermediate endemicity area. Vaccine 19:30, pages 4130-4134.
Crossref
Crossref
Elaine C. Jong. (2001) Risks of Hepatitis A and B in the Traveling Public. Journal of Travel Medicine 8:s1, pages s3-s8.
Crossref
Crossref
Alejandro González-Praetorius, Carmen Gimeno, Julia Bisquert, Carmen Rodríguez-Avial, Cristina Fernández & M Teresa Pérez-Pomata. (2001) Prevalencia de hepatitis A en la provincia de Guadalajara. ¿Es España un país de baja endemia?. Enfermedades Infecciosas y Microbiología Clínica 19:9, pages 428-431.
Crossref
Crossref
Tomas Jelinek & Hans D. Nothdurft. (2006) Changing Epidemiology of Hepatitis A: Time for Vaccination in Childhood. Journal of Travel Medicine 7:3, pages 142-148.
Crossref
Crossref
Rafael Dal-R�, Pilar Garc�a-Corbeira & Juan Garc�a-de-Lomas. (2000) A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A. Journal of Medical Virology 60:4, pages 363-366.
Crossref
Crossref
Mehmet Arslan, Russell H. Wiesner, John J. Poterucha, B.John Gross & Nizar N. Zein. (2000) Hepatitis A antibodies in liver transplant recipients: Evidence for loss of immunity posttransplantation. Liver Transplantation 6:2, pages 191-195.
Crossref
Crossref
Horacio Lopéz, Teresa Zitto, Patricia Baré, Gabriela Vidal, Jorge Vukasovic & Roberto Gómez. (2000) Prevalence of anti-hepatitis A antibodies in an urban middle class area of argentina: some associated factors. International Journal of Infectious Diseases 4:1, pages 34-37.
Crossref
Crossref
F. Martínez-Campillo, M. Terán, M. Álvarez, M.V. Rigo, J. Roda, M. Salinas & J.M. García. (2000) Prevalencia de anticuerpos anti-VHA y eficiencia de la detección prevacunal en instituciones de deficientes psíquicos de la ciudad de Alicante. Atención Primaria 25:8, pages 552-555.
Crossref
Crossref
José-Ramón de Juanes, María-Pilar Arrazola & Antonio González. (2015) Risk of Hepatitis A Among Hospital Personnel in an Intermediate-Endemicity Area. Infection Control & Hospital Epidemiology 20:9, pages 590-591.
Crossref
Crossref
Thomas Löscher, Jay S. Keystone & Robert Steffen. (1999) Vaccination of Travelers against Hepatitis A and B. Journal of Travel Medicine 6:2, pages 107-114.
Crossref
Crossref
H. BarrosF. Oliveira & H. Miranda. (2002) A survey on hepatitis A in Portuguese children and adolescents. Journal of Viral Hepatitis 6:3, pages 249-253.
Crossref
Crossref
A. Gil, A. González, R. Dal-Ré, V. Dominguez, P. Ortega, J.L. Barrio & L. Aguilar. (1999) Prevalence of hepatitis A in an Institution for the mentally retarded in an intermediate endemicity area: Influence of age length of institutionalization. Journal of Infection 38:2, pages 120-123.
Crossref
Crossref
Claudia L Vitral, Clara FT Yoshida, Elba RS Lemos, Christiane S Teixeira & Ana MC Gaspar. (1998) Age-specific Prevalence of Antibodies to Hepatitis A in Children and Adolescents from Rio de Janeiro, Brazil, 1978 and 1995: Relationship of Prevalence to Environmental Factors. Memórias do Instituto Oswaldo Cruz 93:1, pages 1-5.
Crossref
Crossref
A. Gil, A. González, R. Dal-Ré, P. Ortega & V. Dominguez. (1998) Prevalence of antibodies against varicella zoster, herpes simplex (types 1 and 2), hepatitis B and hepatitis A viruses among Spanish adolescents. Journal of Infection 36:1, pages 53-56.
Crossref
Crossref
I. F. Angelillo, C. G. A. Nobile, F. Talarico & Maria Pavia. (1996) Prevalence of hepatitis a antibodies in food handlers in ItalyHepatitis A-Antikörperprävalenz bei Lebensmittel-Händlern in Italien. Infection 24:2, pages 147-150.
Crossref
Crossref
J. Arístegui, E. Garrote, J. L. Morales, Maria S. Gallego, R. Dal-Ré & A. González. (1995) Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years oldSicherheit und Immunogenität einer inaktivierten Hepatitis A-Vakzine bei 2–5 Jahre alten Kindern. Infection 23:5, pages 334-338.
Crossref
Crossref
G. Cilla, E. Perez-Trallero, J. M. Marimon, S. Erdozain & C. Gutierrez. (2009) Prevalence of hepatitis A antibody among disadvantaged gypsy children in northern Spain. Epidemiology and Infection 115:1, pages 157-161.
Crossref
Crossref